Manulife (Manufacturers Life Insurance)
PDLI

Manulife (Manufacturers Life Insurance)’s PDL BioPharma, Inc. PDLI Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-70,799
Closed -$223K – 3096
2020
Q3 		$223K Hold
70,799
– – ﹤0.01% 2500
2020
Q2 		$202K Sell
70,799
-2,342
-3% -$7.41K ﹤0.01% 2500
2020
Q1 		$206K Buy
73,141
+4,009
+6% +$12.9K ﹤0.01% 2309
2019
Q4 		$224K Sell
69,132
-6,368
-8% -$18.5K ﹤0.01% 2517
2019
Q3 		$166K Sell
75,500
-3,443
-4% -$9.2K ﹤0.01% 2673
2019
Q2 		$248K Sell
78,943
-15,820
-17% -$51.3K ﹤0.01% 2492
2019
Q1 		$353K Sell
94,763
-8,102
-8% -$27.4K ﹤0.01% 2210
2018
Q4 		$298K Buy
102,865
+842
+0.8% +$2.31K ﹤0.01% 2169
2018
Q3 		$268K Sell
102,023
-14,927
-13% -$36.6K ﹤0.01% 2592
2018
Q2 		$274K Sell
116,950
-5,929
-5% -$16.6K ﹤0.01% 2860
2018
Q1 		$361K Buy
122,879
+4,638
+4% +$12.7K ﹤0.01% 2572
2017
Q4 		$325K Sell
118,241
-6,547
-5% -$20.1K ﹤0.01% 2631
2017
Q3 		$422K Sell
124,788
-6,120
-5% -$17K ﹤0.01% 2397
2017
Q2 		$323K Sell
130,908
-4,021
-3% -$9.25K ﹤0.01% 2641
2017
Q1 		$306K Buy
134,929
+16,449
+14% +$36.4K ﹤0.01% 2532
2016
Q4 		$251K Buy
118,480
+3,769
+3% +$10.5K ﹤0.01% 2613
2016
Q3 		$385K Buy
114,711
+1,068
+0.9% +$3.39K ﹤0.01% 2249
2016
Q2 		$357K Buy
113,643
+5,739
+5% +$19.1K ﹤0.01% 2250
2016
Q1 		$342K Buy
107,904
+2,001
+2% +$6.24K ﹤0.01% 2236
2015
Q4 		$375 Buy
105,903
+863
+0.8% +$3.61K ﹤0.01% 2198
2015
Q3 		$529 Buy
105,040
+3,674
+4% +$21.1K ﹤0.01% 1969
2015
Q2 		$652 Sell
101,366
-4,017
-4% -$26.9K ﹤0.01% 1942
2015
Q1 		$741 Buy
105,383
+3,496
+3% +$25.3K ﹤0.01% 1850
2014
Q4 		$786 Sell
101,887
-1,078
-1% -$8.53K ﹤0.01% 1729
2014
Q3 		$770 Buy
102,965
+2,123
+2% +$19.7K ﹤0.01% 1727
2014
Q2 		$976K Sell
100,842
-4,506
-4% -$40.2K ﹤0.01% 1595
2014
Q1 		$876 Sell
105,348
-900
-0.8% -$7.71K ﹤0.01% 1719
2013
Q4 		$897 Buy
106,248
+8,797
+9% +$74.1K ﹤0.01% 1671
2013
Q3 		$776 Buy
97,451
+150
+0.2% +$1.21K ﹤0.01% 1715
2013
Q2 		$751K Buy
+97,301
New +$759K ﹤0.01% 1626

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PDLI Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 70,799 shares — an estimated $223K sold.

Manulife (Manufacturers Life Insurance) first reported a position in PDLI in Q2 2013 and held it in 30 quarters. The position peaked at $976K in Q2 2014. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 70,799 PDL BioPharma, Inc. shares in Q4 2020, an estimated $223K.
  • Manulife (Manufacturers Life Insurance) first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 30 quarters.
  • Manulife (Manufacturers Life Insurance)'s PDL BioPharma, Inc. position peaked at $976K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.